4/7/26 20:23 | 4/7/26 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Berkman Charles S | CA | O | GC | M.d | 0 | 0.00 | 0 | 14 | 4 | 399 | D | | | | | | | | | | | | | | |
4/7/26 20:23 | 4/7/26 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Berkman Charles S | CA | O | GC | S.d | -11 | 1.49 | 0 | -7 | -2 | 399 | D | | | | | | | | | | | | | | |
2/18/26 18:36 | 2/18/26 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Berkman Charles S | CA | O | GC | M.d | 0 | 0.00 | 0 | 19 | 5 | 393 | D | | | | | | | | | | | | | | |
2/18/26 18:36 | 2/18/26 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Berkman Charles S | CA | O | GC | S.d | -17 | 1.71 | 0 | -10 | -2 | 393 | D | | | | | | | | | | | | | | |
2/17/26 18:18 | 2/16/26 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Berkman Charles S | CA | O | GC | M.d | 0 | 0.00 | 0 | 14 | 4 | 384 | D | | | | | | | | | | | | | | |
2/17/26 18:18 | 2/17/26 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Berkman Charles S | CA | O | GC | S.d | -12 | 1.70 | 0 | -7 | -2 | 384 | D | | | | | | | | | | | | | | |
12/9/25 09:02 | 12/7/25 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Berkman Charles S | CA | O | GC | M.d | 0 | 0.00 | 0 | 16 | 4 | 377 | D | | | | | | | | | | | | | | |
12/9/25 09:02 | 12/8/25 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Berkman Charles S | CA | O | GC | S.d | -16 | 1.96 | 0 | -8 | -2 | 377 | D | | | | | | | | | | | | | | |
4/7/25 20:10 | 4/7/25 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Berkman Charles S | CA | O | GC | M.d | 0 | 0.00 | 0 | 14 | 4 | 363 | D | | | | | | | | | | | | | | |
4/7/25 20:10 | 4/7/25 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Berkman Charles S | CA | O | GC | S.d | -14 | 2.00 | 0 | -7 | -2 | 363 | D | | | | | | | | | | | | | | |
2/19/25 20:50 | 2/15/25 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Berkman Charles S | CA | O | GC | M.dm | 0 | 0.00 | 0 | 29 | 9 | 357 | D | | | | | | | | | | | | | | |
2/19/25 20:50 | 2/18/25 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Berkman Charles S | CA | O | GC | S.dm | -57 | 3.68 | 0 | -15 | -4 | 357 | D | | | | | | | | | | | | | | |
1/22/25 17:41 | 1/21/25 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Berkman Charles S | CA | O | GC | S | -83 | 3.24 | 0 | -25 | -7 | 343 | D | | | | | | | | | | | | | | |
12/10/24 16:47 | 12/7/24 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Berkman Charles S | CA | O | GC | M.d | 0 | 0.00 | 0 | 16 | 5 | 323 | D | | | | | | | | | | | | | | |
12/10/24 16:47 | 12/9/24 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Berkman Charles S | CA | O | GC | S.d | -33 | 4.13 | 0 | -8 | -2 | 323 | D | | | | | | | | | | | | | | |
4/9/24 18:37 | 4/7/24 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Berkman Charles S | CA | O | GC | M.d | 0 | 0.00 | 0 | 14 | 5 | 293 | D | | | | | | | | | | | | | | |
4/9/24 18:37 | 4/8/24 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Berkman Charles S | CA | O | GC | S.d | -37 | 5.27 | 0 | -7 | -2 | 293 | D | | | | | | | | | | | | | | |
2/20/24 18:22 | 2/15/24 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Berkman Charles S | CA | O | GC | M.d | 0 | 0.00 | 0 | 21 | 8 | 286 | D | | | | | | | | | | | | | | |
1/3/24 17:42 | 1/2/24 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Berkman Charles S | CA | O | GC | M.d | 0 | 0.00 | 0 | 18 | 7 | 272 | D | | | | | | | | | | | | | | |
12/11/23 19:21 | 12/7/23 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Berkman Charles S | CA | O | GC | M.d | 0 | 0.00 | 0 | 16 | 6 | 262 | D | | | | | | | | | | | | | | |